Literature DB >> 26215682

Understanding the benefits and harms of oxygen therapy: response to comments by Akca.

Pierre Asfar1, Mervyn Singer2, Peter Radermacher3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26215682     DOI： 10.1007/s00134-015-3995-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  2 in total

1.  Hyperoxia: is it a biomarker for mortality?

Authors:  Ozan Akca
Journal:  Intensive Care Med       Date:  2015-07-28       Impact factor: 17.440

2.  Understanding the benefits and harms of oxygen therapy.

Authors:  Pierre Asfar; Mervyn Singer; Peter Radermacher
Journal:  Intensive Care Med       Date:  2015-01-30       Impact factor: 17.440
  2 in total
  1 in total

1.  WHO Needs High FIO2?

Authors:  Ozan Akca; Lorenzo Ball; F Javier Belda; Peter Biro; Andrea Cortegiani; Arieh Eden; Carlos Ferrando; Luciano Gattinoni; Zeev Goldik; Cesare Gregoretti; Thomas Hachenberg; Göran Hedenstierna; Harriet W Hopf; Thomas K Hunt; Paolo Pelosi; Motaz Qadan; Daniel I Sessler; Marina Soro; Mert Şentürk
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.